OGN
NYSE · Pharmaceuticals
Organon & Co
$13.29
+0.04 (+0.30%)
Performance
1D
—
1W
—
1M
—
3M
+68.02%
6M
+72.37%
1Y
+52.58%
YTD
+83.56%
Open$13.31
Previous Close$13.25
Day High$13.32
Day Low$13.25
52W High$13.44
52W Low$5.69
Volume—
Avg Volume27.46M
Market Cap3.50B
P/E Ratio18.71
EPS$0.72
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$7.87
Above
SMA 200
$8.85
Above
RSI (14)
32.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Sell
16 analysts
Price Target
+580.2% upside
Current
$13.29
$13.29
Target
$90.40
$90.40
$73.92
$90.40 avg
$125.40
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.27B | 6.26B | 515.23M |
| Net Income | 188.74M | 169.47M | 144.40M |
| Profit Margin | 3.0% | 2.9% | 28.0% |
| EBITDA | 1.11B | 1.05B | 186.20M |
| Free Cash Flow | — | — | 113.95M |
| Rev Growth | +0.2% | +0.2% | +11.5% |
| Debt/Equity | 11.49 | 11.49 | 0.71 |
Dividend
Dividend Yield0.60%
Annual Dividend$0.34
Payout Ratio47.1%
Frequencyquarterly
Ex-DividendMar 29, 2026
Pay DateApr 18, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |